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Abstract
Background: An important question in the development of decision aids about colon cancer (CRC)
screening is whether to include an explicit discussion of the option of not being screened. We examined
the effect of including or not including an explicit discussion of the option of deciding not to be screened
in a CRC screening decision aid on subjective measures of decision aid content; interest in screening; and
knowledge.
Methods: Adults ages 50–85 were assigned to view one of two versions of the decision aid. The two
versions differed only in the inclusion of video segments of two men, one of whom decided against being
screened. Participants completed questionnaires before and after viewing the decision aid to compare
subjective measures of content, screening interest and intent, and knowledge between groups. Likert
response categories (5-point) were used for subjective measures of content (eg. clarity, balance in favor/
against screening, and overall rating), and screening interest. Knowledge was measured with a three item
index and individual questions. Higher scores indicated favorable responses for subjective measures,
greater interest, and better knowledge. For the subjective balance, lower numbers were associated with
the impression of the decision aid favoring CRC screening.
Results: 57 viewed the "with" version which included the two segments and 49 viewed the "without"
version. After viewing, participants found the "without" version to have better subjective clarity about
benefits of screening ("with" 3.4, "without" 4.1, p < 0.01), and to have greater clarity about downsides of
screening ("with" 3.2, "without" 3.6, p = 0.03). The "with" version was considered to be less strongly
balanced in favor of screening. ("with" 1.8, "without" 1.6, p = 0.05); but the "without" version received a
better overall rating ("with" 3.5, "without" 3.8, p = 0.03). Groups did not differ in screening interest after
viewing a decision aid or knowledge.
Conclusion: A decision aid with the explicit discussion of the option of deciding not to be screened
appears to increase the impression that the program was not as strongly in favor of screening, but
decreases the impression of clarity and resulted in a lower overall rating. We did not observe clinically
important or statistically significant differences in interest in screening or knowledge.
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Background
Colorectal cancer screening has been shown to be effective
in reducing the incidence of, and mortality from, colorec-
tal cancer [1]. Several different methods of screening are
available, including fecal occult blood testing, sigmoidos-
copy, combination of occult blood testing and sigmoidos-
copy, colonoscopy, and possibly radiological tests such as
barium enema and CT colography. The United States Pre-
ventive Services Task Force recommends colon cancer
screening for adults age 50 to 75 [1]. Colon cancer screen-
ing was recently determined to be one of the highest pri-
orities for preventive care in the US based on its high
potential for reducing morbidity and mortality, and its
cost-effectiveness [2].
Despite its potential efficacy, colon cancer screening
remains underutilized, with approximately 50% of the
age-eligible population up-to-date with screening in any
form [3]. Several factors account for the low rates of utili-
zation, including patient, provider and systems-related
issues. Low levels of awareness among patients, and poor
provider-patient communication are important barriers:
most unscreened patients have never discussed screening
with their providers [4-6]. Researchers have examined a
number of potential means of addressing these barriers
[7], including efforts to improve clinical decision making.
One potential tool for improving the quality of decision
making and uptake of CRC screening is the use of a
patient decision aid. Patient decision aids are tools devel-
oped to help patients make more informed, value-con-
cordant decisions about health issues. They include
information about the specific decision to be made, pros
and cons of different alternatives, processes for identifying
and clarifying values, and in some cases help with assur-
ing that the patient's input is received and acted upon.
Good decision aids are balanced, clear, and meet the
needs of patients. Systematic reviews of decision aid stud-
ies have shown they can increase knowledge, reduce deci-
sional conflict, and in some cases affect adoption of
health behaviors [8-10].
Existing CRC decision aids [11-14] differ in the questions
on which they focus: some have focused on the decision
about which test to have done, assuming that some form
of screening should be performed; others have addressed
the question of whether or not to be screened [11,14]. An
important question that arises in the development of deci-
sion aids about CRC screening is whether to include an
explicit discussion of the option of not being screened as
a viable alternative.
Proponents of including "no screening" as a viable option
argue that the option of no screening should be included
on the ethical grounds of fully promoting patient auton-
omy by allowing consideration of all possible alternatives
[15,16]. Some also argue that CRC screening produces a
relatively small reduction in the absolute risk of CRC-
related mortality (1–2%) that, for some patients, may not
outweigh the downsides of screening, including discom-
fort with the procedure, time lost from other activities,
and cost. Including an explicit discussion of the option of
"no screening" may also increase credibility of the deci-
sion aid [17-19] by providing a two-sided argument.
Recent guidelines for decision aid developers have sug-
gested that the option of no screening should be included,
but do not comment on whether it should be presented
only as a comparison to active choices or whether it
should always be included as a viable option [20].
On the other hand, some argue that when evidence is felt
to be strongly in favor of screening, as in the case of CRC
screening, only active options should be explicitly dis-
cussed. The inclusion of a viable no screening option in a
decision aid, especially when delivered by an expert,
could confuse patients and result in no screening for
patients who would otherwise choose to be screened.
Others are concerned that despite the relatively small
average reduction and potential for downsides of screen-
ing, CRC screening is relatively beneficial compared with
other services and thus should be endorsed. With this line
of reasoning, patients always have the option not to be
screened, making it unnecessary to present it as a viable
option.
Because both arguments, whether to include or not
include an explicit discussion of not being screened, have
merit and cannot be easily resolved, we sought to perform
a comparative trial of two versions of a CRC screening
decision aid. In this comparative trial we examine more
closely the actual effects of including or not including the
option of no screening as a viable choice. Our main out-
comes were subjective measures of decision aid content,
with secondary outcomes of screening interest and knowl-
edge. Because the differences we were testing were values-
based rather than knowledge-based, we expected that
including or not including the option of no screening
would mainly affect subjective measures of decision aid
content, and possibly interest in screening, but were
unlikely to affect knowledge.
Methods
Overview
Our study of including or not including a discussion of
the option of no screening was part of a larger evaluation
of a CRC screening decision aid sponsored by the Founda-
tion for Informed Medical Decision Making (FIMDM),
which also included a qualitative element not reported
here. Our study used a targeted convenience sample to
evaluate the two versions of the decision aid, one whichBMC Medical Informatics and Decision Making 2008, 8:10 http://www.biomedcentral.com/1472-6947/8/10
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included video segments with an explicit discussion of not
being screened. Three study sites were included in the
evaluation. Each site obtained Institutional Review Board
approval for the study. Eligible patients completed
informed consent at the beginning of their session. Study
sites administered questionnaires prior to focus group dis-
cussions and provided resulting data to be aggregated for
analyses and evaluation.
Decision aid development and context of participant 
evaluation
The content of the CRC screening decision aid was based
on a review of existing literature and was informed by pre-
vious decision aid development [13]. The development
process began with a literature review of existing evidence
and focus groups with patients and providers to identify
the information to be included in the program. The evi-
dence summary focused on information that a patient
would need or should know to make an informed deci-
sion. The evidence summary was then integrated with
results from the focus groups to produce the content doc-
ument that served as the basis for decision aid production.
A draft of the decision aid content then underwent a series
of reviews by clinical and methodological experts. After
this review, a "rough cut" of the decision aid was pro-
duced and used for the final evaluation by experts and
patients. Our trial was completed as part of this final
review process.
Research question
To test the effect of providing the option of no screening
as a viable choice, we produced two versions of the deci-
sion aid that differed only in the inclusion or exclusion of
video segments in which two men (one a physician, the
other a health services researcher) discussed their deci-
sions about CRC screening. In one segment, one of the
men discussed his decision against being screened,
explaining that he felt the potential benefits were not
worth the effort of screening; the other man discussed his
decision to be screened to provide "peace of mind."
The decision aid
Both versions of the decision aid were approximately 35
minutes in duration and were designed to educate
patients and help them to make value-concordant deci-
sions about CRC screening. Both versions first introduced
the topics of colon cancer and screening. Introductory
material also discussed lifetime colon cancer mortality
risk with and without screening and how screening tests
help detect colon cancer. The decision aid oriented view-
ers to the decision(s) they should consider while viewing
the program; whether or not to have screening and, if
screening is desired, which screening test to have. The next
sections of the decision aid described the different types of
colon cancer screening tests including: stool test for
blood, sigmoidoscopy, a combination of stool test for
blood and sigmoidoscopy, colonoscopy, and imaging
tests (barium enema and CT colography). Each test was
described in terms of how the test is completed, how often
it needs to be completed, the amount of time needed to
complete, effectiveness in finding polyps and cancer, con-
venience, discomfort, and risks associated with the test.
The program concludes with the reminder that the indi-
vidual first needs to decide whether or not to have screen-
ing. If they decide to have screening, they can then choose
their preferred test.
Both versions of the decision aid include patients discuss-
ing their decisions about undergoing the different screen-
ing tests. In the version of the decision aid with the
discussion of the option of deciding not to be screened
("with" version), the following segments are also
included approximately 8 minutes into the program for
initial statements and 25 minutes in for second state-
ments.
Endorsement of colon cancer screening; M. Barry, 
Physician
Initial statement
I knew my risk of dying from colon cancer was small, but it was
still on my mind and I reasoned that if I started a screening pro-
gram I could lower that risk enough that I wouldn't have to
worry about it anymore...and less things to worry about is a
good thing in life from my perspective.
Second statement
A particular advantage of colon cancer screening for me is that
by finding and removing polyps I can reduce my chance of get-
ting colon cancer in the first place. Particularly with that
advantage the risk and hassle is worth it for me.
Endorsement of no screening; D. Fryback, Health Services 
Researcher
Initial statement
The cost of being screened for colon cancer and benefits are
things that you have to think about. For me, the benefit's small.
I think that there is not much chance of dying from colon cancer
and reducing that small chance to a little smaller chance comes
at a price.
Second statement
What are my chances of dying from colon cancer in my life-
time? The chance is very small, it is very, very small, and it
doesn't go to zero if you get screened. What happens is that you
get a small chance cut in half, if that, and that small change is
just not worth it to me.
These segments were not included in the "without" ver-
sion of the decision aid. Both versions of the decision aid
concluded with information designed to aid viewers inBMC Medical Informatics and Decision Making 2008, 8:10 http://www.biomedcentral.com/1472-6947/8/10
Page 4 of 9
(page number not for citation purposes)
their decision process by having them think about their
choices/options and what was right for them based on
their values and beliefs. To assist viewers in the decision-
making process, the program provided information com-
paring the different tests on aspects such as effectiveness
and risks.
Participants
Men and women ages 50–85 were recruited from three
different communities (two in the Northeast and one in
the Southeast of the United States). Sites were part of an
existing collaborative effort sponsored by the FIMDM to
evaluate decision aids. Recruiting technique varied by
each site and included print advertising, telephone
recruiting, and recruiting from a marketing database. Each
site used a targeted convenience sample with the goal of
recruiting approximately 12 participants to a group. Par-
ticipants were assigned non-randomly to sex-specific
groups that viewed either the decision aid version with the
discussion of the no testing option or the version without
this information (Figure 1). Non-random assignment was
based on gender and the availability of the participant on
scheduled focus groups dates. Men and women partici-
pated in different groups to remove the potential discom-
fort of discussing a sensitive subject with the opposite sex
present [21].
Measures
Our primary outcomes were subjective measures of deci-
sion aid content such as clarity and balance, and our sec-
ondary measures included knowledge and interest and
intent to be screened. These measures were drawn from
previous studies by our group, from previous evaluations
used by the FIMDM, and a review of the key content of the
decision aid (see Additional File 1 for questionnaires used
in this study).
We assessed subjective measures of content after decision
aid viewing, including the amount and clarity of informa-
tion presented, and overall impression of the decision aid,
using 5-point Likert response categories. The response cat-
egories used for amount of information were: 1- much
less than I wanted, 2- a little less that I wanted, 3- about
right, 4- a little more than I wanted, and 5- much more
than I wanted. Lower scores were associated with the
impression that the decision aid provided less informa-
Study diagram Figure 1
Study diagram.BMC Medical Informatics and Decision Making 2008, 8:10 http://www.biomedcentral.com/1472-6947/8/10
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tion that wanted and higher scores with more information
than was wanted. Other subjective measures, including
clarity of information, ability to sort out what was impor-
tant, ability to help make a decision, and overall impres-
sion of the decision aid, used response categories of: 1-
Poor, 2- Fair, 3- Good, 4-Very Good, 5-Excellent. Higher
numbers were associated with better subjective impres-
sions of amount of information on advantages and disad-
vantages of screening, ability to sort out what was
important, ability to help make a decision, and overall
impression of the decision aid. For the subjective balance
of the decision aid, lower numbers were associated with
the impression of the decision aid favoring CRC screening
and higher numbers against screening: Do you think the
video was: 1- Strongly in favor of screening, 2- Somewhat
in favor of screening, 3- Neither in favor of nor against
screening, 4- Somewhat against screening, 5-Strongly
against screening.
Interest and screening intent were assessed in all partici-
pants after viewing the decision aid, but were measured
before decision aid viewing only for those who had not
completed a colonoscopy within the last 10 years. Those
who had completed other screening tests were able to
respond to this question before viewing the decision aid
because they could have chosen additional screening after
learning about other options. The 5-point Likert response
categories used for interest included: 1- Definitely not
interested in being screened, 2- Probably not interested in
being screened, 3- Not sure if I am interested or not, 4-
Probably interested in being screened, 5- Definitely inter-
ested in being screened. The 4-point Likert response cate-
gories for intent were 1- Definitely don't intend to ask for
screening, 2- Probably don't intend to ask for screening, 3-
Probably intend to ask for screening, 4-Definitely intend
to ask for screening. For both of these variables; higher
scores were associated with greater interest in or intent for
screening.
Participant knowledge was assessed before and after view-
ing the decision aid. Knowledge questions were devel-
oped based on the researchers' and developers'
assessment of key content of the decision aid. We assessed
knowledge to ensure that including or not including the
discussion of no screening did not result in significant dif-
ferences between the groups. The pre-decision aid knowl-
edge index included three questions; the post decision aid
knowledge index included these 3 questions and added
two additional questions (five in total). These additional
questions were not included in the pre decision aid ques-
tionnaire to keep participants from focusing on these spe-
cific points while viewing the decision aid. Scores for the
3-item index were computed with 1 point awarded for a
correct response with a range of scores from 0 to 3. The
two additional post-questionnaire knowledge questions
were assessed separately.
We considered other measures, including decisional con-
flict, but decided against them to keep the questionnaire
at a manageable length. Because we had identified a
strong relationship between interest or intent to be
screened after viewing and the subsequent completion of
a CRC screening test in our earlier trial, we elected not to
measure screening completion in this study [13].
Statistical analyses
We used SAS software [22] and SPSS [23] for our analyses.
Descriptive statistics were calculated for each variable.
Due to skewed distributions, we used nonparametric Wil-
coxon Rank Sum tests to compare subjective measures
and screening interest and intent between groups after
decision aid viewing. Wilcoxon Rank Sum tests were also
used to compare pre knowledge scores between groups
and post knowledge scores between groups. We used lin-
ear regression to determine whether age, sex, race, educa-
tion level, screening status, or pre knowledge scores
confounded the relationships of decision aid version with
our outcome variables.
Results
Study population
Figure 1 shows the number of participants viewing each
video. One hundred six adults participated in 12 total ses-
sions at the three study sites. Each site conducted 4 focus
groups sessions: two using the "with" version of the deci-
sion aid (1 male and 1 female session) and two using the
"without" version of the decision aid (1 male and 1
female session).
Participants' mean age was 60, with a range of 50 to 81. A
slight majority of participants were women (53%). Sev-
enty six percent were white, and 22% were African Amer-
ican. Most participants (60%) had a 4-year college degree
or more. Almost three quarters (72%) of participants were
up-to-date with recommended colon cancer screening;
18% of participants had completed a home stool blood
test (FOBT) within the last year, 19% completed sig-
moidoscopy in the last five years, and 56% completed
colonoscopy in the last ten years. There were moderate
differences between groups in sex and being up-to-date
with screening. We found no significant differences in pre-
knowledge ("with" version 2.0, "without" version 2.1, p =
0.40) scores among those who viewed the "with" version
compared with those viewing the "without" version
(Table 1).BMC Medical Informatics and Decision Making 2008, 8:10 http://www.biomedcentral.com/1472-6947/8/10
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Subjective impressions of amount, clarity, and balance of 
information
Table 2 shows that the "without" version was found to
have better clarity of information on benefits, clarity of
information on downsides, amount of information on
downsides of screening, and helping patients prepare for
making a decision. For both versions, 16% of participants
indicated that the decision aid was "balanced"; however,
most indicated that it was either strongly or somewhat in
favor of screening. The "with" version, which included the
discussion of the no screening option, was scored as being
less strongly in favor of screening, but scored lower on
overall impression than the "without" version. The two
versions did not differ in other subjective measures,
including amount of information on benefits and sorting
out what was important.
Differences in knowledge between groups
We found no significant differences in post-knowledge
("with" version 2.3, "without" version 2.3, p  = 0.72)
scores among those who viewed the "with" version com-
pared with those viewing the "without" version. Change
scores did not differ significantly either ("with" version
+0.37, "without" version +0.24, p = 0.35). We also did not
find any significant difference between the groups on the
two additional knowledge questions included on the
post-questionnaire. Eighty-seven percent viewing the
"with" version and 86% of those viewing the "without"
version correctly answered that most polyps will not
develop into cancer if not removed (p = 0.78). Ninety-
seven percent viewing the "with" version and 98% view-
ing the "without" version correctly responded that less
than 10 out of 100 adults would develop colon cancer
over their lifetime (p = 1.00).
Interest and intent for screening post decision aid between 
groups
No significant differences were identified in interest and
intent among all participants responding after viewing the
decision aid (Table 3), or in the sub-group of participants
not up-to-date with screening (data not shown).
Table 1: Demographics by group
"With" Version (with discussion of not screening)
(n = 57)
"Without" Version
(n = 49)
p-value
Mean Age 60 ± 7.0 60 ± 6.3 0.68
Sex- Female 60% 45% 0.17
Education Level* 0.77
Some college/2-year degree or less 40% 35%
4-year college degree 21% 19%
More than 4-year college degree 39% 46%
Race 0.86
White 77% 71%
Black/African American 19% 25%
Up-To-Date with Screening 79% 63% 0.09
Pre-Knowledge Score† 2.0 2.1 0.40
* n = 48 for "without version"
† Knowledge scores computed with 1 for correct 0 for incorrect and not answered; range 0–3, Wilcoxon Rank Sum test statistic
Table 2: Subjective ratings of videos by group
"With" Version (with discussion of not screening)
Mean
n = 57
"Without" Version
Mean
n = 49
p-value
Clarity of information on benefits* 3.4 4.0 <0.01
Amount of information on benefits* 2.9 2.9 0.72
Clarity of information on downsides 3.2 3.6 0.03
Amount of information on downsides 2.7 3.0 0.02
Helped me sort what was important 3.5 3.8 0.13
Helped me prepare for making a decision† 3.5 3.9 0.03
Balance† 1.8 1.6 0.05
Overall rating of video† 3.5 3.8 0.03
Measured with 5 point Likert response categories, Wilcoxon Rank Sum test statistic
† n = 56 for "with" version
* n = 48 for "without" versionBMC Medical Informatics and Decision Making 2008, 8:10 http://www.biomedcentral.com/1472-6947/8/10
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Multivariate analyses
Relationships between version and subjective measures,
interest, or knowledge, did not change when we control-
led for age, sex, race, education level, screening status, or
pre-knowledge scores in multiple linear regression.
Discussion
In a comparative trial, we evaluated two versions of a deci-
sion aid that differed only in the inclusion or exclusion of
two segments, one of which included an explicit discus-
sion and endorsement of the option of deciding not to be
screened. The version with the explicit discussion of the
option of no screening ("with" version) was rated subjec-
tively as less strongly in favor of CRC screening, but had
lower subjective rating of clarity and a lower overall rat-
ing. We found no statistically significant or clinically
important differences between versions in terms of inter-
est or intent for screening, or knowledge.
We are unaware of other studies that have directly com-
pared including or not including information describing
the option of "no screening" within the same decision aid.
Two previous CRC decision aid studies included informa-
tion about the option of not being screened and com-
pared it against a minimal information control group.
Both studies were small, but did not find differences in
screening between groups [11,14]. The decision aid by
Wolf and colleagues included this explicit statement that
"another option is to not be tested at all, unless signs of
colon cancer develop, though at that point, cancer is less
likely to be curable" [14]. Dolan and colleagues used an
analytical hierarchy model for "choosing [the] best
approach for colorectal cancer screening" which included
a "wait & see" option that described the option of not
being screened [11]. Previous iterations of a CRC decision
aid developed by our team have not included the explicit
option of "no screening" and have shown increases in
interest and intent to be screened, as well as actual
increases in screening rates [13].
A number of questions arise when determining the con-
tent of decision aids including the amount and type of
information that they should attempt to communicate. In
another lab-based study, we have explored the amount of
screening information provided, namely the number of
screening tests discussed in a decision aid [24]. This work
also found that the number of tests discussed in a decision
aid did not affect interest in screening.
Another question to consider is who communicates the
information in a decision aid. The "with" version of the
decision aid included an endorsement of the option of no
screening by a health services researcher and to balance
this, a physician endorsing the option to be screened.
Opposing endorsements may have contributed to the per-
ception of balance in this version but also may have
reduced clarity. Although we did not test the specific effect
of expert versus non-expert endorsements, nor the type of
expert providing the endorsement, the subjective differ-
ences noted between the two versions may be affected by
endorsements and who provides them.
In this case, the endorser of the option of no screening
placed considerable value on the time requirements for
screening and made a judgment about the chance of a
potential benefit of screening relative to this time cost. If
the viewer holds a different value for his or her time, or
feels differently about the chance of benefit, he or she may
be misled by the endorser's conclusion. Neutral represen-
tation of the options, both by a narrator or even graphical
representations, may produce different effects, and should
be compared in a future study [25]. Testing the effect of
vignettes versus other methods is a high priority for
research [26].
Our study has several limitations. First, it is a small study,
which does not allow us to definitively rule out small but
meaningful differences between groups. We examined
several subjective outcomes, and did not adjust for multi-
ple comparisons, so our findings should be interpreted
cautiously. Second, the knowledge questions that we used
did not evaluate participant's knowledge of the relative
risks and benefits of the various screening options. Hence,
they may not be ideal for evaluating whether the decision
aid fulfilled the goal of educating patients about the rela-
tive risks and benefits of the various screening options
available. Third, we did not measure actual screening
behavior, so it is possible that the two versions would
have different effects on that endpoint. Our previous stud-
ies have found strong correlations between interest or
Table 3: Screening interest and intent by group all participants responding post video
"With" Version (with discussion of not screening)
Mean
"Without" Version
Mean
p-value
Interest in screening† 3.4 3.5 0.54
Intent to be screened*‡ 2.9 2.8 0.65
† n = 53 for "with" version and n = 45 for "without" version
* n = 50 for "with" version and n = 46 for "without" version
‡Measured on a 4-point Likert Scale, Wilcoxon Rank Sum test statisticBMC Medical Informatics and Decision Making 2008, 8:10 http://www.biomedcentral.com/1472-6947/8/10
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intent and actual test completion suggesting that those
who indicate interest and intent are more likely to com-
plete screening [13]. Nevertheless, our findings should be
confirmed in a larger randomized trial of unscreened indi-
viduals viewing the decision aid that also measures
whether screening is completed. In addition, we did not
assign participants randomly to the two study groups,
instead allocating by gender and participant availability.
We did note some differences between groups at baseline,
but controlling for them did not affect our findings. We
had diverse geographic representation, but our partici-
pants were volunteers, the majority had undergone some
form of screening, and were highly educated, affecting the
finding's generalizability to other clinical populations.
It is also important to note that the amount of the deci-
sion aid devoted to the discussion of "no screening" was
less than two minutes in a 35 minute program, and that
overall both programs were seen as favoring screening.
The differences between the decision aids were mainly
related to the effect of how the health services researcher
and physician interviewed with opposing views on screen-
ing valued the magnitude of benefit from screening and
did not differ in terms of factual information on risks and
benefits. It is possible that our results would differ if a
greater proportion of time was spent on discussion of the
option of "no screening."
Our study examines the question of colorectal cancer
screening, where the evidence of benefit is relatively
strong and its magnitude of effect relatively large. These
results may not generalize to other decisions where the
evidence is more uncertain, such as prostate cancer screen-
ing, mammography for women in their forties, or deci-
sions about heart disease prevention.
Conclusion
We believe our study provides important information for
researchers and developers of decision aids and those who
seek to increase their use in clinical practice. Including an
explicit discussion of the option of "no screening" appears
to increase the impression of "balance" away from
strongly favoring screening but decreases the impression
of clarity and overall rating, without large effects on
screening interest, intentions, or knowledge. Further
research is required to better understand the optimal con-
tent of decision aids that will promote better quality deci-
sion making.
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